Integrated DNA Technologies

www.idtdna.com

Integrated DNA Technologies (IDT) is a major manufacturer of custom products for the research and diagnostic life science market. IDT is also the world leader in nucleic acid synthesis and serves the areas of academic research, biotechnology, and pharmaceutical development.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

INTEGRATED DNA TECHNOLOGIES SHIPS QPCR MASTER MIX AT AMBIENT TEMPERATURE

Integrated DNA Technologies | November 02, 2016

news image

Integrated DNA Technologies (“IDT”) has developed a unique master mix for probe-based qPCR assays that is stable for ambient shipping. The company’s PrimeTime® Gene Expression Master Mix is the only widely distributed commercial master mix shipped in solution at ambient temperature. Under these conditions, the master mix, which is compatible with a wide range of real-time PCR instruments, continues to deliver consistent, high quality results....

Read More

INTEGRATED DNA TECHNOLOGIES EXPANDS GLOBAL SALES DISTRIBUTION NETWORK

Integrated DNA Technologies | June 02, 2016

news image

Integrated DNA Technologies (“IDT”), the global leader in custom nucleic acid synthesis, has acquired MBiotech, Inc. (“MBiotech”), headquartered in Seoul, South Korea. MBiotech has been a distributor of IDT products for more than a decade. In its promotion of IDT products, MBiotech has successfully made IDT’s brand well-known throughout the South Korean peninsula. The company also distributes products for other manufacturers. These other products include reagents, e...

Read More

A FUTURE GENE THERAPY COULD BE DELIVERED IN TINY ‘NANOCONTAINERS���

Labiotech.eu | January 28, 2020

news image

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient at their job, viral vectors can risk triggering the immune system to destroy them. This can lead to the therapy becoming ineffective....

Read More

J&J JUMPING IN ON CORONAVIRUS VAX WORK AS DISEASE CONTINUES ITS SPREAD

FierceBiotech | January 27, 2020

news image

Johnson & Johnson is joining the growing ranks of biopharmas, including the likes of Moderna and Gilead Sciences, in trying to create a speedy vaccine for the coronavirus out of China. Over the weekend, we learned of a wider range and more deaths as the new virus, which appears to have come out of Wuhan, China, is doing what these diseases do best: spread. The causes of death have so far been reported as pneumonia, with other reports suggesting most of these have come from those with underly...

Read More
news image

INTEGRATED DNA TECHNOLOGIES SHIPS QPCR MASTER MIX AT AMBIENT TEMPERATURE

Integrated DNA Technologies | November 02, 2016

Integrated DNA Technologies (“IDT”) has developed a unique master mix for probe-based qPCR assays that is stable for ambient shipping. The company’s PrimeTime® Gene Expression Master Mix is the only widely distributed commercial master mix shipped in solution at ambient temperature. Under these conditions, the master mix, which is compatible with a wide range of real-time PCR instruments, continues to deliver consistent, high quality results....

Read More
news image

INTEGRATED DNA TECHNOLOGIES EXPANDS GLOBAL SALES DISTRIBUTION NETWORK

Integrated DNA Technologies | June 02, 2016

Integrated DNA Technologies (“IDT”), the global leader in custom nucleic acid synthesis, has acquired MBiotech, Inc. (“MBiotech”), headquartered in Seoul, South Korea. MBiotech has been a distributor of IDT products for more than a decade. In its promotion of IDT products, MBiotech has successfully made IDT’s brand well-known throughout the South Korean peninsula. The company also distributes products for other manufacturers. These other products include reagents, e...

Read More
news image

A FUTURE GENE THERAPY COULD BE DELIVERED IN TINY ‘NANOCONTAINERS���

Labiotech.eu | January 28, 2020

A Swiss research group has developed tiny plastic particles that could carry gene therapies to the center of the cell with less risk of getting attacked by the immune system than conventional gene therapies. The majority of gene therapies in use today are delivered to the DNA of target cells using viral vectors. While efficient at their job, viral vectors can risk triggering the immune system to destroy them. This can lead to the therapy becoming ineffective....

Read More
news image

J&J JUMPING IN ON CORONAVIRUS VAX WORK AS DISEASE CONTINUES ITS SPREAD

FierceBiotech | January 27, 2020

Johnson & Johnson is joining the growing ranks of biopharmas, including the likes of Moderna and Gilead Sciences, in trying to create a speedy vaccine for the coronavirus out of China. Over the weekend, we learned of a wider range and more deaths as the new virus, which appears to have come out of Wuhan, China, is doing what these diseases do best: spread. The causes of death have so far been reported as pneumonia, with other reports suggesting most of these have come from those with underly...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us